SCHEMBL23369215

SCHEMBL23369215

CC(C)N1CN(C(C)C)c2cc(OC(C)(C)CCO)ccc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23966192 0.74 L3MBTL1 (0.34) —
SCHEMBL23369232 0.71 — —
SCHEMBL16525775 0.70 MAOA (0.40) —
SCHEMBL24613022 0.68 — —
SCHEMBL23468940 0.67 CYP1A2 (0.46) —
SCHEMBL23966170 0.67 CARM1 (0.37) —
SCHEMBL23366503 0.66 KDM4E (0.39) —
SCHEMBL23366510 0.66 KDM4E (0.35) —
SCHEMBL26277295 0.65 ABL1 (0.36) —
SCHEMBL22461066 0.64 AR (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3821982-A1 SUBSTRATE FOR NUCLEIC ACID AMPLIFICATION, AND METHOD FOR MANUFACTURING SAME Korea Research Institute of Bioscience and Biotechnology (KR) 2021-05-19 — — EP disclosed
Send feedback